As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Antifungal Drugs Market: By Drug Class: Azoles, Echinocandins, Polyenes, Allylamines, Others; By Indication: Dermatophytosis, Aspergillosis, Candidiasis, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: Swot Analysis; Competitive Landscape; Industry Events and Developments

Global Antifungal Drugs Market Outlook

The global antifungal drugs market stood at a value of around USD 13.2 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 5% to reach USD 18.8 billion by 2026.

 

Significant Growth of the Azoles Segment to Bolster the Growth of the Antifungal Drugs Industry

Based on drug class, the azoles segment accounts for a significant share in the market and is anticipated to witness a considerable growth in the forecast period. Azoles are used to treat a wide range of conditions, including yeast infection, tinea versicolor, and athlete's foot, and are available in different formulations, such as capsules, lotions, and sterile IV solutions, among others. These drugs offer improved absorption and distribution properties with fewer side effects and less serious drug interactions.

 

Global Antifungal Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

These factors have been contributing to the growth of the segment. Over the forecast period, the rising demand for azoles in combination with other antifungal agents to treat systematic and superficial fungal infections is likely to be a major factor driving the market. In addition to this, the growing cases of candidemia, blastomycosis, systematic candidiasis, and ocular fungal infections, among others are likely to aid the segment growth in the coming years.

 

North America Accounts for a Significant Share in the Antifungal Drugs Industry

North America accounts for a significant market share in the antifungal drugs industry due to the improved healthcare infrastructure, rise in echinocandin resistance, and the growing cases of fungal infections in the region.  The growing pharmaceutical industry and the presence of the leading companies in the region are supporting the market growth in North America. Moreover, the increasing commercialisation of drugs is expected to further contribute to the antifungal drugs industry growth in the region.

 

Antifungal Drugs: Industry Definition and Segmentation

Antifungal drugs can be defined as a type of drug that helps eliminate fungal infection from the body with minimum toxic side effects. Antifungal drugs basically act against fungal pathogens and are used in the treatment of fungal infections.

Based on drug class, the market is segmented into:

  • Azoles 
    • Voriconazole 
    • Posaconazole 
    • Isavuconazole (CRESEMBA) 
    • Others 
  • Echinocandins 
    • Caspofungin 
    • Micafungin (Mycamine/ Funguard) 
    • Others 
  • Polyenes 
    • Amphotericin (AmBisome) 
    • Others 
  • Allylamines 
    • Terbinafine
    • Others
  • Others 

On the basis of indication, the industry is divided into:

  • Dermatophytosis 
  • Aspergillosis 
  • Candidiasis 
    • Invasive Candidiasis 
    • Vulvovaginal Candidiasis (VVC) 
    • Mouth/Throat/Esophageal Candidiasis 
    • Others 
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Growing Risk of Fungal Infections to Boost the Growth of the Antifungal Drugs Industry

The global market for antifungal drugs is driven by the growing prevalence of fungal infections across the globe. The increasing consumption of unhealthy food, which might compromise the immune system, is likely to increase the risk of fungal infections, which, in turn, is expected to propel the demand for antifungal drugs. Furthermore, the rising geriatric population,  which is more susceptible to fungal infections such as ringworm, candidiasis, and systematic mycosis, among others, is significantly contributing to the market growth.

Over the forecast period, the growing investments by the leading pharmaceutical companies to develop novel and more effective drugs for fungal diseases are anticipated to augment the market growth in the forecast period.

 

Key Industry Players in the Global Antifungal Drugs Market

The report gives a detailed analysis of the following key players in the global antifungal drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Abbott Laboratories
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pfizer Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug Class, Indication, Region
Breakup by Drug Class Azoles, Echinocandins, Polyenes, Allylamines, Others
Breakup by Indication Dermatophytosis, Aspergillosis, Candidiasis, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Abbott Laboratories, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Antifungal Drugs Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Antifungal Drugs Historical Market (2017-2021) 
    8.3    Global Antifungal Drugs Market Forecast (2022-2027)
    8.4    Global Antifungal Drugs Market by Drug Class 
        8.4.1    Azoles
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    Voriconazole
                8.4.1.4.2    Posaconazole
                8.4.1.4.3    Isavuconazole (CRESEMBA)
                8.4.1.4.4    Others
        8.4.2    Echinocandins
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
            8.4.2.4    Breakup by Type
                8.4.2.4.1    Caspofungin
                8.4.2.4.2    Micafungin (Mycamine/ Funguard)
                8.4.2.4.3    Others
        8.4.3    Polyenes
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
            8.4.3.4    Breakup by Type 
                8.4.3.4.1    Amphotericin (AmBisome)
                8.4.3.4.2    Others
        8.4.4    Allylamines
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
                8.4.4.3.1    Terbinafine
                8.4.4.3.2    Others
        8.4.5    Others
    8.5    Global Antifungal Drugs Market by Indication
        8.5.1    Dermatophytosis
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Aspergillosis
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Candidiasis
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
                8.5.3.3.1    Invasive Candidiasis
                8.5.3.3.2    Vulvovaginal Candidiasis (VVC)
                8.5.3.3.3    Mouth/Throat/Esophageal Candidiasis
                8.5.3.3.4    Others
        8.5.4    Others
    8.6    Global Antifungal Drugs Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Abbott Laboratories
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    GlaxoSmithKline PLC
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Novartis AG
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Pfizer Inc.
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Others
12    Industry Events and Developments

 

List of Figures and Tables

1.    Global Antifungal Drugs Market: Key Industry Highlights, 2016 and 2026
2.    Global Antifungal Drugs Historical Market: Breakup by Drug Class (USD Billion), 2017-2021
3.    Global Antifungal Drugs Market Forecast: Breakup by Drug Class (USD Billion), 2022-2027
4.    Global Antifungal Drugs Historical Market: Breakup by Indication (USD Billion), 2017-2021
5.    Global Antifungal Drugs Market Forecast: Breakup by Indication (USD Billion), 2022-2027
6.    Global Antifungal Drugs Historical Market: Breakup by Region (USD Billion), 2017-2021
7.    Global Antifungal Drugs Market Forecast: Breakup by Region (USD Billion), 2022-2027
8.    North America Antifungal Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
9.    North America Antifungal Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
10.    Europe Antifungal Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    Europe Antifungal Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Asia Pacific Antifungal Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Asia Pacific Antifungal Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Latin America Antifungal Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Latin America Antifungal Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Middle East and Africa Antifungal Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Middle East and Africa Antifungal Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Global Antifungal Drugs Market Structure

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER